Mirosław Zagaja, Anna Zagaja, Joanna Szala-Rycaj, Aleksandra Szewczyk, Agnieszka Maruszewska, Jarogniew Łuszczki, Marta Andres-Mach
{"title":"Influence of bee venom on antinociceptive activity of selected analgesic drugs in hot plate test in mice.","authors":"Mirosław Zagaja, Anna Zagaja, Joanna Szala-Rycaj, Aleksandra Szewczyk, Agnieszka Maruszewska, Jarogniew Łuszczki, Marta Andres-Mach","doi":"10.26444/aaem/195108","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction and objective: </strong>The aim of the study was to investigate the effect of bee venom on the activity of two analgesics: ketoprofen (a non-steroidal anti-inflammatory drug) and tramadol (an opioid drug) in the acute thermal pain model (hot-plate test) in mice.</p><p><strong>Material and methods: </strong>Linear regression analysis was used to evaluate the dose-response relationship between logarithms of drug doses and their resultant maximum possible anti-nociceptive effects in the mouse hot-plate test. Doses that increased the anti-nociceptive effect by 20% (ED<sub>20</sub> values) for bee venom, ketoprofen and tramadol, and their combination were calculated from linear equations. The interaction between bee venom and the selected anaglesics was evaluated using isobolographic analysis.</p><p><strong>Results: </strong>The study showed that all compounds produced a definite anti-nociceptive effect, and the experimentally-derived ED<sub>20</sub> values for bee venom, ketoprofen and tramadol, when applied indivisually, was 3.64 mg/kg, 79.88 mg/kg and 13.26 mg/kg, respectively. Isobolographic analysis revealed that the combination of bee venom and ketoprofen at a fixed ratio of 1:1 was supra-additive (synergistic). The experimentally-derived ED<sub>20 mix</sub> was 26.33 mg/kg, which significantly differed from the ED<sub>20</sub> <sub>add</sub> of 41.76 mg/kg (p < 0.5). The experimentally-derived ED<sub>20</sub> <sub>mix</sub> of bee venom and tramadol was 2.90 mg/kg, and differed significantly from the theoretically estimated ED<sub>20</sub><sub> add</sub> of 8.45 mg/kg (p < 0.5), also indicating a synergistic interaction in the hot-plate test in mice. Moreover, none of the tested combinations indicated any adverse effects in the chimney test and the grip-strength test in mice.</p><p><strong>Conclusions: </strong>Overall, the obtained results demonstrated that bee venom significantly increased the anti-nociceptive activity of ketoprofen and tramadol in the hot-plate model of nociceptive pain in mice.</p>","PeriodicalId":50970,"journal":{"name":"Annals of Agricultural and Environmental Medicine","volume":"31 4","pages":"506-512"},"PeriodicalIF":1.3000,"publicationDate":"2024-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Agricultural and Environmental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26444/aaem/195108","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/22 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction and objective: The aim of the study was to investigate the effect of bee venom on the activity of two analgesics: ketoprofen (a non-steroidal anti-inflammatory drug) and tramadol (an opioid drug) in the acute thermal pain model (hot-plate test) in mice.
Material and methods: Linear regression analysis was used to evaluate the dose-response relationship between logarithms of drug doses and their resultant maximum possible anti-nociceptive effects in the mouse hot-plate test. Doses that increased the anti-nociceptive effect by 20% (ED20 values) for bee venom, ketoprofen and tramadol, and their combination were calculated from linear equations. The interaction between bee venom and the selected anaglesics was evaluated using isobolographic analysis.
Results: The study showed that all compounds produced a definite anti-nociceptive effect, and the experimentally-derived ED20 values for bee venom, ketoprofen and tramadol, when applied indivisually, was 3.64 mg/kg, 79.88 mg/kg and 13.26 mg/kg, respectively. Isobolographic analysis revealed that the combination of bee venom and ketoprofen at a fixed ratio of 1:1 was supra-additive (synergistic). The experimentally-derived ED20 mix was 26.33 mg/kg, which significantly differed from the ED20add of 41.76 mg/kg (p < 0.5). The experimentally-derived ED20mix of bee venom and tramadol was 2.90 mg/kg, and differed significantly from the theoretically estimated ED20 add of 8.45 mg/kg (p < 0.5), also indicating a synergistic interaction in the hot-plate test in mice. Moreover, none of the tested combinations indicated any adverse effects in the chimney test and the grip-strength test in mice.
Conclusions: Overall, the obtained results demonstrated that bee venom significantly increased the anti-nociceptive activity of ketoprofen and tramadol in the hot-plate model of nociceptive pain in mice.
期刊介绍:
All papers within the scope indicated by the following sections of the journal may be submitted:
Biological agents posing occupational risk in agriculture, forestry, food industry and wood industry and diseases caused by these agents (zoonoses, allergic and immunotoxic diseases).
Health effects of chemical pollutants in agricultural areas , including occupational and non-occupational effects of agricultural chemicals (pesticides, fertilizers) and effects of industrial disposal (heavy metals, sulphur, etc.) contaminating the atmosphere, soil and water.
Exposure to physical hazards associated with the use of machinery in agriculture and forestry: noise, vibration, dust.
Prevention of occupational diseases in agriculture, forestry, food industry and wood industry.
Work-related accidents and injuries in agriculture, forestry, food industry and wood industry: incidence, causes, social aspects and prevention.
State of the health of rural communities depending on various factors: social factors, accessibility of medical care, etc.